Long ride, bad ride - Recensione dipendente - TMS Clinical Operator presso Celularity

2,0
22 feb 2023
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Most people, at least in TM are nice! Young people are taking over the job.

Svantaggi

Company hid financials from everyone for too long. People worked more than a year and a half without a hint of being converted to FTEs. When the company finally converted a few people, a week later or so it announced a mass lay off of pretty much 90% of the workforce. Months before this, the CEO would announce the promotion of executives and higher ups by email to everyone like contractors (that have waited long to make a few mor dollars and get benefits) would even want to celebrate. The CEO is narcissistic, and probably a conservative. Makes no sense sometimes. Back in thanksgiving (just a bit prior) they laid off many people with NO notice. Then in a meeting the CEO suggested they were lazy people and bad workers. Meanwhile, many of them were amazing workers, some even doing more than several people that remained. Now, the company is going down, and they are trying to keep as many people as possible after announcing mass lay offs, but just to “finish the job”. This company will dispose of you at their will.

Esplora altre recensioni su Celularity

5,0
18 giu 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Company works hard to foster a family like environment with a lot of fun activities to offset the hard work and dedication of employees.

Svantaggi

Biotech industry as a whole has had struggles with uncertainty and reduced investor activity. Redirection and refocus are needed to sustain long term.

4,0
10 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

They acknowledge everyone’s contributions. Work family.

Svantaggi

Slow growth for certain levels.

Vedi recensioni per: Utile|Valutazione|Data|Tutto